Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc

<< Previous

Bullboard Posts

Next >>

Post by TechOneon Oct 11, 2024 3:50pm

152 Views

Post# 36263212

Spectral on Linkedin Today

Endotoxic septic shock, caused by high endotoxin levels in the bloodstream, can lead to severe organ failure and in severe cases can be fatal. However, not all septic shock cases are driven by endotoxins, so early and accurate detection is essential.

By measuring endotoxin levels, healthcare teams can quickly identify patients with endotoxic septic shock and provide targeted treatments, such as extracorporeal methods to remove endotoxins. This precision approach not only improves outcomes, but may also optimize resources by focusing on the patients who will benefit most. Learn more https://ow.ly/yqJ150TJC8w

<< Previous

Bullboard Posts

Next >>

Bombardier delivers Global 6500 aircraft to U.S. Army